Kraig Biocraft Laboratories (KBLB) Total Current Liabilities (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Total Current Liabilities across 16 years of filings, most recently posting $10.4 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $10.4 million, up 8.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.4 million (up 8.64% YoY), and the FY2025 annual result was $10.4 million, up 8.64% from the prior year.
• Total Current Liabilities came in at $10.4 million for Q4 2025 at Kraig Biocraft Laboratories, up from $10.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $10.4 million in Q4 2025 to a low of $7.8 million in Q1 2021.
• The 5-year median for Total Current Liabilities is $8.9 million (2023), against an average of $9.0 million.
• Across the five-year window, Total Current Liabilities surged 35.98% in 2021 and fell 8.58% in 2023, its largest moves.
• Kraig Biocraft Laboratories' Total Current Liabilities stood at $8.2 million in 2021, then slipped by 1.11% to $8.1 million in 2022, then rose by 10.08% to $8.9 million in 2023, then grew by 8.2% to $9.6 million in 2024, then rose by 8.64% to $10.4 million in 2025.
• The last three Total Current Liabilities figures came in at $10.4 million (Q4 2025), $10.2 million (Q3 2025), and $10.0 million (Q2 2025), per Business Quant data.